It is not yet clear why the efficiency of RNA editing might be affected in AD, but one likely upstream cause may be dysregulation of the adenosine deaminases acting on RNA (ADAR) enzymes responsible for the most common form of editing, adenosine to inosine (A-to-I). Here, ADA is linked to Alzheimer disease.